RTX Trademark

Trademark Overview


On Tuesday, August 7, 2018, a trademark application was filed for RTX with the United States Patent and Trademark Office. The USPTO has given the RTX trademark a serial number of 88067737. The federal status of this trademark filing is REGISTERED as of Tuesday, April 28, 2020. This trademark is owned by Rubius Therapeutics, Inc.. The RTX trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
rtx

General Information


Serial Number88067737
Word MarkRTX
Filing DateTuesday, August 7, 2018
Status700 - REGISTERED
Status DateTuesday, April 28, 2020
Registration Number6043278
Registration DateTuesday, April 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2019

Trademark Statements


Goods and ServicesCells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 13, 2018
Primary Code005
First Use Anywhere DateTuesday, October 15, 2019
First Use In Commerce DateTuesday, October 15, 2019

Trademark Owner History


Party NameRubius Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameRubius Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameRubius Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, January 1, 2019PUBLISHED FOR OPPOSITION
Monday, August 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 26, 2018ASSIGNED TO EXAMINER
Monday, November 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 6, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 23, 2019SOU EXTENSION 1 FILED
Friday, August 23, 2019SOU EXTENSION 1 GRANTED
Tuesday, January 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 6, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 23, 2019SOU TEAS EXTENSION RECEIVED
Thursday, February 20, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, February 20, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2020SOU EXTENSION 2 FILED
Thursday, February 20, 2020USE AMENDMENT FILED
Wednesday, March 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 4, 2020SOU EXTENSION 2 GRANTED
Wednesday, March 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 4, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 28, 2020REGISTERED-PRINCIPAL REGISTER
Monday, April 28, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED